Research ExplorerPublicationsRole of secondary cytoreductive surgery in ovarian cancer re...

Role of secondary cytoreductive surgery in ovarian cancer relapse: who will benefit? A systematic analysis of 240 consecutive patients.

Standard

Role of secondary cytoreductive surgery in ovarian cancer relapse: who will benefit? A systematic analysis of 240 consecutive patients. / Sehouli, Jalid; Richter, R; Braicu, Elena Ioana; Bühling, Kai J.; Bahra, Marcus; Neuhaus, Peter; Lichtenegger, Werner; Fotopoulou, Christina.

In: J SURG ONCOL, Vol. 102, No. 6, 6, 2010, p. 656-662.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Sehouli, J, Richter, R, Braicu, EI, Bühling, KJ, Bahra, M, Neuhaus, P, Lichtenegger, W & Fotopoulou, C 2010, 'Role of secondary cytoreductive surgery in ovarian cancer relapse: who will benefit? A systematic analysis of 240 consecutive patients.', J SURG ONCOL, vol. 102, no. 6, 6, pp. 656-662. <http://www.ncbi.nlm.nih.gov/pubmed/20734422?dopt=Citation>

APA

Sehouli, J., Richter, R., Braicu, E. I., Bühling, K. J., Bahra, M., Neuhaus, P., Lichtenegger, W., & Fotopoulou, C. (2010). Role of secondary cytoreductive surgery in ovarian cancer relapse: who will benefit? A systematic analysis of 240 consecutive patients. J SURG ONCOL, 102(6), 656-662. [6]. http://www.ncbi.nlm.nih.gov/pubmed/20734422?dopt=Citation

Vancouver

Sehouli J, Richter R, Braicu EI, Bühling KJ, Bahra M, Neuhaus P et al. Role of secondary cytoreductive surgery in ovarian cancer relapse: who will benefit? A systematic analysis of 240 consecutive patients. J SURG ONCOL. 2010;102(6):656-662. 6.

Bibtex

@article{52af85c01f374c289c4b523babac6f1c,
title = "Role of secondary cytoreductive surgery in ovarian cancer relapse: who will benefit? A systematic analysis of 240 consecutive patients.",
abstract = "In contrast to primary ovarian cancer, the value of surgery in relapsed-OC (ROC) remains unclear. We evaluated surgical and clinical outcome of secondary cytoreduction in ROC.",
author = "Jalid Sehouli and R Richter and Braicu, {Elena Ioana} and B{\"u}hling, {Kai J.} and Marcus Bahra and Peter Neuhaus and Werner Lichtenegger and Christina Fotopoulou",
year = "2010",
language = "Deutsch",
volume = "102",
pages = "656--662",
journal = "J SURG ONCOL",
issn = "0022-4790",
publisher = "Wiley-Liss Inc.",
number = "6",

}

RIS

TY - JOUR

T1 - Role of secondary cytoreductive surgery in ovarian cancer relapse: who will benefit? A systematic analysis of 240 consecutive patients.

AU - Sehouli, Jalid

AU - Richter, R

AU - Braicu, Elena Ioana

AU - Bühling, Kai J.

AU - Bahra, Marcus

AU - Neuhaus, Peter

AU - Lichtenegger, Werner

AU - Fotopoulou, Christina

PY - 2010

Y1 - 2010

N2 - In contrast to primary ovarian cancer, the value of surgery in relapsed-OC (ROC) remains unclear. We evaluated surgical and clinical outcome of secondary cytoreduction in ROC.

AB - In contrast to primary ovarian cancer, the value of surgery in relapsed-OC (ROC) remains unclear. We evaluated surgical and clinical outcome of secondary cytoreduction in ROC.

M3 - SCORING: Zeitschriftenaufsatz

VL - 102

SP - 656

EP - 662

JO - J SURG ONCOL

JF - J SURG ONCOL

SN - 0022-4790

IS - 6

M1 - 6

ER -